Does TAMSULOSIN Cause Malignant neoplasm progression? 45 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Malignant neoplasm progression have been filed in association with TAMSULOSIN (Tamsulosin Hydrochloride). This represents 0.3% of all adverse event reports for TAMSULOSIN.
45
Reports of Malignant neoplasm progression with TAMSULOSIN
0.3%
of all TAMSULOSIN reports
3
Deaths
26
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TAMSULOSIN?
Of the 45 reports, 3 (6.7%) resulted in death, 26 (57.8%) required hospitalization, and 1 (2.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAMSULOSIN. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does TAMSULOSIN Cause?
Dizziness (1,736)
Dyspnoea (1,375)
Drug ineffective (1,005)
Fall (960)
Syncope (904)
Hypotension (896)
Fatigue (871)
Off label use (844)
Asthenia (701)
Headache (699)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TAMSULOSIN Alternatives Have Lower Malignant neoplasm progression Risk?
TAMSULOSIN vs TAPENTADOL
TAMSULOSIN vs TAPINAROF
TAMSULOSIN vs TARCEVA
TAMSULOSIN vs TARLATAMAB
TAMSULOSIN vs TARLATAMAB-DLLE